Tirdzniecība Sientra, Inc. - SIEN CFD
Pievienot izlasei- Kopsavilkums
- Vēsturiskie Dati
- Notikumi
- Peļņas Atskaite
- Bilance
- Naudas Plūsma
- Īpašums
Tirdzniecības Nosacījumi
| Starpība | - | ||||||||
|
Garās pozīcijas nodeva naktij
Long position overnight fee
Doties uz platformu | -0.030779% | ||||||||
|
Īsās pozīcijas nodeva naktij
Short position overnight fee
Doties uz platformu | -0.013666% | ||||||||
| Nakts laika nodeva | 22:00 (UTC) | ||||||||
| Min. tirgotais daudzums | 1 | ||||||||
| Valūta | USD | ||||||||
| Drošības rezerve | 20% | ||||||||
| Fondu birža | United States of America | ||||||||
| Tirdzniecības komisija | 0% |
*Information provided by Capital.com
Galvenie Statistikas Dati
| Iepriekš. aizvērt* | N/A |
| Atvērt* | N/A |
| Izmaiņas par 1 gadu* | N/A |
| Dienas Diapazons* | N/A |
| 52 ned Diapazons | 1.49-33.80 |
| Vidējais apjoms (10 dienas) | 450.72K |
| Vidējais apjoms (3 mēneši) | 4.11M |
| Tirgus Kapitalizācija | 21.41M |
| Cenas/Peļņas Attiecība | -100.00K |
| Izvietotās Akcijas | 10.10M |
| Ieņēmumi | 88.13M |
| EPS | -10.89 |
| Dividende (Ienesīgums %) | N/A |
| Beta | 1.60 |
| Nākamās Peļņas Datums | Mar 21, 2023 |
"Visus datus nodrošina Refinitiv, izņemot datus, kas atzīmēti ar zvaigznīti, kas ir *dati, kurus nodrošina Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Aizvēršana | Change | Change (%) | Atvēršana | High | Low |
|---|
Sientra, Inc. Events
| Time (UTC) | Country | Event |
|---|---|---|
| No events scheduled | ||
- Ikgadējs
- Ceturkšņa
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Kopējie ienākumi | 20.734 | 36.542 | 68.126 | 83.699 | 54.997 | 80.683 |
| Ienākumi | 20.734 | 36.542 | 68.126 | 83.699 | 54.997 | 80.683 |
| Cost of Revenue, Total | 6.88 | 14.171 | 26.822 | 33.012 | 23.599 | 36.348 |
| Bruto Peļņa | 13.854 | 22.371 | 41.304 | 50.687 | 31.398 | 44.335 |
| Kopējie Darbības Izdevumi | 60.768 | 99.432 | 147.9 | 187.266 | 102.408 | 127.033 |
| Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 44.184 | 65.448 | 110.133 | 126.96 | 69.715 | 80.229 |
| Pētniecība un Attīstība | 9.704 | 9.813 | 10.945 | 13.537 | 8.704 | 10.456 |
| Neparedzēti Izdevumi (Ienākumi) | 0 | 10 | 0 | 13.757 | 0.39 | 0 |
| Darbības Izdevumi | -40.034 | -62.89 | -79.774 | -103.567 | -47.411 | -46.35 |
| Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | -0.035 | -1.06 | -2.896 | -3.166 | -19.713 | -22.718 |
| Citi, Neto | -0.036 | -0.095 | 0.039 | -0.051 | 0.045 | 6.57 |
| Neto Ienākumi Pirms Nodokļu Nomaksas | -40.105 | -64.045 | -82.631 | -106.784 | -67.079 | -62.498 |
| Neto Ienākumi Pēc Nodokļu Nomaksas | -40.166 | -29.473 | -82.627 | -106.818 | -67.112 | -62.519 |
| Neto Ienākumi Pirms Ārkārtas Posteņiem | -40.166 | -29.473 | -82.627 | -106.818 | -67.112 | -62.519 |
| Neto Ienākumi | -40.166 | -64.028 | -82.627 | -106.818 | -89.947 | -62.482 |
| Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | -40.166 | -29.473 | -82.627 | -106.818 | -67.112 | -62.519 |
| Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | -40.166 | -64.028 | -82.627 | -106.818 | -89.947 | -62.482 |
| Atšķaidītie Neto Ienākumi | -40.166 | -64.028 | -82.627 | -106.818 | -89.947 | -62.482 |
| Atšķaidītie Ienākumi par Akcijām | 18.2332 | 19.1591 | 25.4022 | 40.6543 | 50.2332 | 57.0571 |
| Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | -2.20291 | -1.53833 | -3.25274 | -2.62747 | -1.33601 | -1.09573 |
| Atšķaidītā Normalizētā Peļņa par Akciju | -2.20291 | -1.19907 | -3.25274 | -2.40752 | -1.33096 | -1.09573 |
| Ārkārtas Posteņi Kopā | -34.555 | 0 | -22.835 | 0.037 |
| Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
|---|---|---|---|---|---|
| Kopējie ienākumi | 18.312 | 20.103 | 19.62 | 22.648 | 21.398 |
| Ienākumi | 18.312 | 20.103 | 19.62 | 22.648 | 21.398 |
| Cost of Revenue, Total | 8.159 | 8.838 | 9.03 | 10.321 | 8.553 |
| Bruto Peļņa | 10.153 | 11.265 | 10.59 | 12.327 | 12.845 |
| Kopējie Darbības Izdevumi | 30.084 | 29.26 | 31.314 | 36.375 | 37.493 |
| Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 19.73 | 18.022 | 19.917 | 22.56 | 25.796 |
| Pētniecība un Attīstība | 2.195 | 2.4 | 2.367 | 3.494 | 3.144 |
| Darbības Izdevumi | -11.772 | -9.157 | -11.694 | -13.727 | -16.095 |
| Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | -44.744 | -9.384 | 33.523 | -2.113 | -1.896 |
| Citi, Neto | -0.095 | 0.002 | 6.674 | -0.011 | 0.006 |
| Neto Ienākumi Pirms Nodokļu Nomaksas | -56.611 | -18.539 | 28.503 | -15.851 | -17.985 |
| Neto Ienākumi Pēc Nodokļu Nomaksas | -56.611 | -18.539 | 28.503 | -15.872 | -17.985 |
| Neto Ienākumi Pirms Ārkārtas Posteņiem | -56.611 | -18.539 | 28.503 | -15.872 | -17.985 |
| Ārkārtas Posteņi Kopā | 1.921 | -1.595 | -0.093 | -0.196 | -0.056 |
| Neto Ienākumi | -54.69 | -20.134 | 28.41 | -16.068 | -18.041 |
| Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | -56.611 | -18.539 | 28.503 | -15.872 | -17.985 |
| Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | -54.69 | -20.134 | 28.41 | -16.068 | -18.041 |
| Atšķaidītie Neto Ienākumi | -54.69 | -20.134 | 28.41 | -16.068 | -18.041 |
| Atšķaidītie Ienākumi par Akcijām | 54.3212 | 57.6479 | 58.0058 | 58.1703 | 62.3341 |
| Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | -1.04215 | -0.32159 | 0.49138 | -0.27285 | -0.28853 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Atšķaidītā Normalizētā Peļņa par Akciju | -1.04215 | -0.32159 | 0.49138 | -0.27285 | -0.28853 |
| Neparedzēti Izdevumi (Ienākumi) | 0 | 0 |
- Ikgadējs
- Ceturkšņa
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Apgrozāmo Līdzekļu Kopsumma | 100.005 | 55.565 | 136.123 | 157.257 | 129.272 | 140.774 |
| Nauda un Īstermiņa Ieguldījumi | 67.212 | 26.588 | 86.899 | 87.608 | 54.967 | 51.772 |
| Nauda un Ekvivalenti | 67.212 | 26.588 | 86.899 | 87.608 | 54.967 | 51.772 |
| Debitoru Parādu Kopsumma, Neto | 12.457 | 6.608 | 22.527 | 27.548 | 23.503 | 33.105 |
| Accounts Receivable - Trade, Net | 3.082 | 6.569 | 22.527 | 27.548 | 23.503 | 33.105 |
| Total Inventory | 18.484 | 20.896 | 24.085 | 39.612 | 48.648 | 52.914 |
| Prepaid Expenses | 1.852 | 1.473 | 2.612 | 2.489 | 2.154 | 2.979 |
| Total Assets | 114.283 | 92.213 | 168.359 | 204.404 | 168.978 | 199.904 |
| Property/Plant/Equipment, Total - Net | 2.986 | 4.763 | 2.536 | 19.886 | 20.44 | 20.563 |
| Property/Plant/Equipment, Total - Gross | 4.178 | 6.804 | 5.033 | 23.695 | 27.162 | 28.814 |
| Accumulated Depreciation, Total | -1.192 | -2.041 | -2.497 | -3.809 | -6.722 | -8.251 |
| Goodwill, Net | 4.878 | 12.507 | 12.507 | 9.202 | 9.202 | 9.202 |
| Intangibles, Net | 6.186 | 18.803 | 16.495 | 17.39 | 9.387 | 28.765 |
| Other Long Term Assets, Total | 0.228 | 0.575 | 0.698 | 0.669 | 0.677 | 0.6 |
| Total Current Liabilities | 27.521 | 50.347 | 64.141 | 70.47 | 70.66 | 80.018 |
| Accounts Payable | 3.555 | 5.811 | 13.184 | 9.352 | 6.504 | 7.402 |
| Accrued Expenses | 3.933 | 8.761 | 13.179 | 17.651 | 14.159 | 11.64 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 20.033 | 11.136 | 30.912 | 36.919 | 45.243 | 58.668 |
| Total Liabilities | 30.666 | 64.59 | 101.481 | 122.522 | 169.535 | 159.047 |
| Total Long Term Debt | 0 | 0 | 27.883 | 38.283 | 60.577 | 62.462 |
| Long Term Debt | 0 | 27.883 | 38.248 | 60.5 | 62.434 | |
| Other Liabilities, Total | 3.145 | 14.243 | 9.425 | 13.719 | 38.226 | 16.567 |
| Total Equity | 83.617 | 27.623 | 66.878 | 81.882 | -0.557 | 40.857 |
| Common Stock | 0.186 | 0.194 | 0.286 | 0.495 | 0.506 | 0.622 |
| Additional Paid-In Capital | 299.133 | 307.159 | 428.949 | 550.562 | 558.059 | 661.839 |
| Retained Earnings (Accumulated Deficit) | -215.442 | -279.47 | -362.097 | -468.915 | -558.862 | -621.344 |
| Treasury Stock - Common | -0.26 | -0.26 | -0.26 | -0.26 | -0.26 | -0.26 |
| Total Liabilities & Shareholders’ Equity | 114.283 | 92.213 | 168.359 | 204.404 | 168.978 | 199.904 |
| Total Common Shares Outstanding | 18.5987 | 19.402 | 28.6288 | 49.5402 | 50.6394 | 62.1694 |
| Current Port. of LT Debt/Capital Leases | 24.639 | 6.866 | 6.548 | 4.754 | 2.308 | |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | ||||
| Deferred Income Tax | 0.032 | 0.05 | 0.072 | |||
| Capital Lease Obligations | 0.035 | 0.077 | 0.028 | |||
| Other Current Assets, Total | 0.004 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Apgrozāmo Līdzekļu Kopsumma | 159.169 | 151.538 | 146.776 | 140.774 | 134.937 |
| Nauda un Īstermiņa Ieguldījumi | 80.372 | 82.417 | 66.127 | 51.772 | 38.883 |
| Nauda un Ekvivalenti | 80.372 | 82.417 | 66.127 | 51.772 | 38.883 |
| Debitoru Parādu Kopsumma, Neto | 25.438 | 21.319 | 26.453 | 33.105 | 39.265 |
| Accounts Receivable - Trade, Net | 25.438 | 21.319 | 26.453 | 33.105 | 39.265 |
| Total Inventory | 50.556 | 45.306 | 51.529 | 52.914 | 54.224 |
| Prepaid Expenses | 2.803 | 2.492 | 2.663 | 2.979 | 2.561 |
| Total Assets | 198.413 | 190.532 | 186.658 | 199.904 | 191.866 |
| Property/Plant/Equipment, Total - Net | 20.29 | 20.333 | 21.507 | 20.563 | 19.25 |
| Property/Plant/Equipment, Total - Gross | 28.038 | 27.05 | 28.818 | 28.814 | 28.39 |
| Accumulated Depreciation, Total | -7.748 | -6.717 | -7.311 | -8.251 | -9.14 |
| Goodwill, Net | 9.202 | 9.202 | 9.202 | 9.202 | 9.202 |
| Intangibles, Net | 9.081 | 8.776 | 8.471 | 28.765 | 27.89 |
| Other Long Term Assets, Total | 0.671 | 0.683 | 0.702 | 0.6 | 0.587 |
| Total Current Liabilities | 69.576 | 72.085 | 71.677 | 80.018 | 84.65 |
| Accounts Payable | 3.845 | 6.369 | 6.3 | 7.402 | 9.112 |
| Accrued Expenses | 10.041 | 8.245 | 10.226 | 11.64 | 8.557 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 5.899 | 6.73 | 0.075 | 2.308 | 5.261 |
| Other Current Liabilities, Total | 49.791 | 50.741 | 55.076 | 58.668 | 61.72 |
| Total Liabilities | 211.354 | 221.408 | 145.896 | 159.047 | 166.78 |
| Total Long Term Debt | 60.605 | 60.63 | 61.524 | 62.462 | 65.582 |
| Long Term Debt | 60.54 | 60.577 | 61.483 | 62.434 | 65.565 |
| Capital Lease Obligations | 0.065 | 0.053 | 0.041 | 0.028 | 0.017 |
| Other Liabilities, Total | 81.173 | 88.693 | 12.695 | 16.567 | 16.548 |
| Total Equity | -12.941 | -30.876 | 40.762 | 40.857 | 25.086 |
| Common Stock | 0.574 | 0.579 | 0.581 | 0.622 | 0.625 |
| Additional Paid-In Capital | 600.297 | 602.491 | 645.717 | 661.839 | 664.106 |
| Retained Earnings (Accumulated Deficit) | -613.552 | -633.686 | -605.276 | -621.344 | -639.385 |
| Treasury Stock - Common | -0.26 | -0.26 | -0.26 | -0.26 | -0.26 |
| Total Liabilities & Shareholders’ Equity | 198.413 | 190.532 | 186.658 | 199.904 | 191.866 |
| Total Common Shares Outstanding | 57.4424 | 57.8564 | 58.0569 | 62.1694 | 62.4802 |
| Other Current Assets, Total | 0.004 | 0.004 | 0.004 | 0.004 | |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 |
- Ikgadējs
- Ceturkšņa
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Neto ienākumi/Sākuma Līnija | -40.166 | -64.028 | -82.627 | -106.818 | -67.112 | -62.519 |
| Nauda no Darbības | -34.43 | -45.878 | -56.19 | -87.033 | -60.138 | -42.5 |
| Nauda no Darbības | 1.177 | 3.034 | 3.321 | 3.524 | 3.37 | 4.36 |
| Deferred Taxes | 0.061 | -0.021 | -0.008 | 0.018 | ||
| Bezskaidras Naudas Preces | 5.331 | 12.98 | 20.279 | 31.761 | 12.61 | 24.863 |
| Samaksātie Procenti Naudā | 0.096 | 0.87 | 3.12 | 4.089 | 4.198 | 4.193 |
| Izmaiņas Apgrozāmajā Kapitālā | -0.833 | 2.157 | 2.845 | -15.518 | -9.006 | -9.204 |
| Nauda no Ieguldījumu Darbībām | -12.835 | -20.014 | -0.855 | -22.014 | -4.036 | 3.329 |
| Kapitālie Izdevumi | -1.126 | -1.864 | -0.855 | -4.071 | -3.956 | -3.805 |
| Citi Ieguldījumu Naudas Plūsmas Posteņi, Kopā | -11.709 | -18.15 | 0 | -17.943 | -0.08 | 7.134 |
| Nauda no Darbībām ar Finansēšanu | 1.676 | 25.611 | 117.356 | 109.756 | 31.523 | 35.938 |
| Naudas Plūsma Finansēšanas Posteņos | 0 | -1.382 | -2.337 | -10.827 | -4.749 | -8.495 |
| Akciju Izsniegšana (Atkāpšanās), Neto | 1.676 | 1.993 | 109.693 | 109.075 | 1.128 | 41.196 |
| Parādu Izsniegšana (Atkāpšanās), Neto | 0 | 25 | 10 | 11.508 | 35.144 | 3.237 |
| Neto Izmaiņas Naudā | -45.589 | -40.281 | 60.311 | 0.709 | -32.651 | -3.233 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -54.69 | -75.15 | -46.647 | -62.519 | -17.985 |
| Cash From Operating Activities | -12.667 | -15.102 | -29.552 | -42.5 | -17.915 |
| Cash From Operating Activities | 1.384 | 2.11 | 3.149 | 4.36 | 1.744 |
| Non-Cash Items | 46.953 | 56.797 | 17.935 | 24.863 | 3.688 |
| Cash Interest Paid | 1.058 | 2.082 | 3.133 | 4.193 | 1.07 |
| Changes in Working Capital | -6.314 | 1.141 | -3.989 | -9.204 | -5.362 |
| Cash From Investing Activities | -1.321 | 8.144 | 6.432 | 3.329 | -0.246 |
| Capital Expenditures | -1.321 | -3.17 | -4.882 | -3.805 | -0.246 |
| Cash From Financing Activities | 39.393 | 34.408 | 34.28 | 35.938 | 5.271 |
| Financing Cash Flow Items | -1.965 | -7.292 | -7.77 | -8.495 | -0.28 |
| Issuance (Retirement) of Stock, Net | 40.358 | 40.7 | 41.05 | 41.196 | 0.329 |
| Issuance (Retirement) of Debt, Net | 1 | 1 | 1 | 3.237 | 5.222 |
| Net Change in Cash | 25.405 | 27.45 | 11.16 | -3.233 | -12.89 |
| Other Investing Cash Flow Items, Total | 11.314 | 11.314 | 7.134 | 0 |
| Investora vārds | Investora veids | Nenokārtots procents | Akcijas turējumā | Izmaiņas akcijās | Turēšanas termiņš | Apgrozījuma reitings |
|---|---|---|---|---|---|---|
| Pessin (Norman H) | Individual Investor | 5.615 | 567092 | 567092 | 2022-11-09 | LOW |
| Morgan Stanley & Co. LLC | Research Firm | 2.9865 | 301621 | -21370 | 2022-09-30 | MED |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.7903 | 281807 | 13767 | 2022-09-30 | LOW |
| Clarus Ventures, LLC | Venture Capital | 2.7038 | 273077 | 0 | 2022-09-30 | MED |
| Baron Capital Management, Inc. | Investment Advisor/Hedge Fund | 2.5529 | 257836 | 0 | 2022-09-30 | LOW |
| Needham Investment Management L.L.C. | Investment Advisor/Hedge Fund | 2.2971 | 232000 | 20165 | 2022-09-30 | LOW |
| Abingworth Management Limited | Venture Capital | 1.6571 | 167359 | 0 | 2022-09-30 | LOW |
| Stifel Nicolaus Investment Advisors | Investment Advisor | 1.2352 | 124750 | 47743 | 2022-09-30 | LOW |
| Millennium Management LLC | Hedge Fund | 1.1854 | 119716 | -79216 | 2022-09-30 | HIGH |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.9716 | 98123 | -3167 | 2022-09-30 | LOW |
| First Eagle Investment Management, L.L.C. | Investment Advisor/Hedge Fund | 0.9602 | 96981 | 26832 | 2022-09-30 | LOW |
| Mutual of America Capital Management LLC | Investment Advisor | 0.9521 | 96160 | 796 | 2022-09-30 | LOW |
| Pessin (Brian L) | Individual Investor | 0.8664 | 87500 | 87500 | 2022-11-09 | |
| GSA Capital Partners LLP | Hedge Fund | 0.8059 | 81388 | 53877 | 2022-09-30 | HIGH |
| AWM Investment Company, Inc. | Investment Advisor/Hedge Fund | 0.7919 | 79977 | -139122 | 2022-09-30 | LOW |
| Woodline Partners LP | Hedge Fund | 0.6726 | 67933 | -43827 | 2022-09-30 | HIGH |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.5817 | 58748 | 230 | 2022-09-30 | LOW |
| BofA Global Research (US) | Research Firm | 0.4899 | 49476 | 41734 | 2022-09-30 | LOW |
| Maven Securities | Investment Advisor | 0.4456 | 45000 | 20000 | 2021-06-30 | |
| Hightower Advisors, LLC | Investment Advisor | 0.4198 | 42398 | 0 | 2022-09-30 | LOW |
Kāpēc izvēlēties Capital.com? Mūsu skaitļi runā paši par sevi.
Capital.com Group +485000+
Tirgotāji
65000+
Ikmēneša aktīvie klienti
$48000000+
Ikmēneša ieguldījumu apjoms
$28000000+
Izmēģināt tagad Izņemts katru mēnesi
Treidinga kalkulators
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Tirdzniecības komisija
0
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
Finanšu svira
20:1
- 20
- 100
- 500
- 1000
- 10000
Investīcija
Darījuma apjoms (Kredītplecs x Investīcija):
Atvēršana
Aizvēršana
Īss Garšs
Sientra, Inc. Company profile
Par Sientra, Inc.
Sientra, Inc. ir medicīnas estētikas uzņēmums. Uzņēmuma galvenie produkti ir silikona gēla krūšu implanti, kurus izmanto krūšu palielināšanas un krūšu rekonstrukcijas procedūrās un kurus tas piedāvā vairāk nekā 400 formu, izmēru un faktūru variācijās. Uzņēmums pārdod savus krūšu implantus un krūšu audu paplašinātājus jeb krūšu produktus plastikas ķirurgiem. Tās krūšu implanti galvenokārt tiek izmantoti plānveida procedūrās, kuras parasti tiek veiktas, maksājot skaidrā naudā. Implanta tekstūra nodrošina implanta apvalka teksturēšanu, kas paredzēta, lai samazinātu nepareizas novietojuma, rotācijas un kapsulārās kontraktūras rašanās biežumu. Uzņēmums piedāvā arī krūts audu paplašinātājus rekonstrukcijas procedūrām, galvenokārt slimnīcām un ķirurģijas centriem, un savus BIOCORNEUM rētu pārvaldības produktus plastiskajiem ķirurgiem, dermatologiem un citu specialitāšu speciālistiem. Uzņēmuma zīmoli ir arī OPUS, Luxe, Curve, AlloX2, Dermaspan un Softspan.
| Industry: | Medical Equipment, Supplies & Distribution (NEC) |
420 South Fairview Avenue
Suite 200
SANTA BARBARA
CALIFORNIA 93117
US
Peļņas Atskaite
- Annual
- Quarterly
Cilvēki arī skatās
Vai joprojām meklējat mākleri, kuram varat uzticēties?
Pievienojieties 485 000+ tirgotājiem visā pasaulē, kuri izvēlējās tirgoties ar Capital.com